Table 3.
Day-7 mortality and time to discharge. Multivariable analysis.
| Adjusted Odds Ratio (OR) | Adjusted Hazard Ratio (aHR) & | |||
|---|---|---|---|---|
| (n = 1158) | (n = 1167) | |||
| aOR, (95% CI) | p-Value | aHR, (95% CI) | p-Value | |
| NSAID | 0.79 (0.32–1.92) | 0.602 | 0.89 (0.59–1.35) | 0.58 |
| Age | ||||
| Under 65 | -Ref- | -Ref- | ||
| 65 to 79 | 3.80 (2.26–6.37) | <0.001 | 0.76 (0.61–0.95) | 0.02 |
| Over 80 | 5.14 (3.04–8.69) | <0.001 | 0.56 (0.44–0.73) | <0.001 |
| Sex | ||||
| Female | -Ref- | -Ref- | ||
| Male | 0.81 (0.57–1.14) | 0.227 | 0.92 (0.76–1.11) | 0.37 |
| Smoking status | ||||
| Never | ||||
| Ex-smokers | 1.17 (0.83–1.67) | 0.372 | 0.95 (0.78–1.15) | 0.61 |
| Current smokers | 1.12 (0.54–2.33) | 0.765 | 1.04 (0.73–1.48) | 0.84 |
| Elevated CRP (>40) | 4.91 (2.99–8.06) | <0.001 | 0.69 (0.57–0.84) | <0.001 |
| Patients with diabetes | 1.04 (0.71–1.52) | 0.838 | 0.84 (0.68–1.04) | 0.12 |
| Patients with CAD | 1.46 (1.00–2.13) | 0.051 | 1.12 (0.88–1.42) | 0.36 |
| Patients with hypertension | 0.78 (0.55–1.10) | 0.157 | 0.95 (0.79–1.16) | 0.63 |
| Patients with reduced renal function (eGFR < 60) | 2.02 (1.42–2.86) | <0.001 | 0.92 (0.75–1.13) | 0.58 |
& The multivariable mixed-effects analysis was adjusted for age group, sex, smoking, CRP level, diabetes, CAD, hypertension and renal function.